ARDENT GROUP, LLC

Ardent Group, LLC provides pharmaceutical benefit manager (PBM) services to federal agencies, with demonstrated experience supporting the Department of Homeland Security’s Immigration and Customs Enforcement (ICE) in managing medication access and pharmacy operations within detention facilities. Their core capability centers on administering end-to-end pharmaceutical programs, including formulary management, claims adjudication, network provider contracting, and medication utilization review—all tailored to the unique regulatory and operational constraints of custodial environments. The firm specializes in ensuring compliance with federal pharmacy standards while optimizing drug supply chains for high-risk, low-resource settings, demonstrating expertise in controlled substance protocols, formulary alignment with DHS guidelines, and integrated pharmacy information systems. Their approach emphasizes clinical oversight, cost containment, and audit readiness in environments where patient care must meet both medical and security requirements. The company’s primary agency engagement is with DHS/ICE, where it delivers pharmacy services critical to inmate health management under federal detention compliance frameworks. This relationship suggests a focused, mission-aligned partnership centered on sustaining continuity of care in correctional healthcare systems. While no NAICS classification is available in the award history, the nature of the work aligns with pharmaceutical and health services contracting within federal detention and immigration operations, positioning Ardent Group as a niche provider in correctional pharmacy management. Ardent Group, LLC operates as a small, specialized firm without publicly disclosed certifications or geographic footprint details. Its market positioning is defined by its ability to deliver compliant, operationally resilient PBM services in high-security federal environments, serving a critical but underserved segment of the government healthcare ecosystem.